SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
SIOX
Delisted
SIOX was delisted on the 22nd of March, 2023.
61 hedge funds and large institutions have $22.8M invested in Sio Gene Therapies Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 24 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
59% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 17
Holders
61
Holding in Top 10
–
Calls
$1.48M
Puts
$1.09M
Top Buyers
| 1 | +$1.91M | |
| 2 | +$576K | |
| 3 | +$411K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$155K |
| 5 |
JPMorgan Chase & Co
New York
|
+$46K |
Top Sellers
| 1 | -$1.13M | |
| 2 | -$1.07M | |
| 3 | -$725K | |
| 4 |
Two Sigma Investments
New York
|
-$612K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$356K |